...
首页> 外文期刊>Acta tropica: Journal of Biomedical Sciences >Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon
【24h】

Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon

机译:吡喹酮的功效和再感染方式在喀麦隆肠道和泌尿生殖道血吸虫病的单一和混合感染灶中的作用

获取原文
获取原文并翻译 | 示例

摘要

The regular administration of the anthelminthic drug praziquantel (PZQ) to school-aged children (and other high-risk groups) is the cornerstone of schistosomiasis control. Whilst the performance of PZQ against single schistosome species infections is well-known, performance against mixed species infections is less so, as are patterns of re-infection following treatment. To address this, a study using a double treatment with PZQ, administered at 40. mg/kg spaced by 3 weeks, took place in two mixed intestinal-urogenital schistosomiasis foci in northern Cameroon (Bessoum and Ouro-Doukoudje) and in one single intestinal schistosomiasis infection focus (Makenene). A total of just under 1000 children were examined and the Schistosoma-infected children were re-examined at several parasitological follow-ups over a 1-year period posttreatment. Overall cure rates against Schistosoma spp. in the three settings were good, 83.3% (95% confidence interval (CI) = 77.9-87.7%) in Bessoum, 89.0% (95% CI = 79.1-94.6%) in Ouro Doukoudje, and 95.3% (95% CI = 89.5-98.0%) in Makenene. Interestingly, no case of mixed schistosome infection was found after treatment. Cure rates for S. mansoni varied from 99.5% to 100%, while that for S. haematobium were considerably lower, varying from 82.7% to 88.0%. Across transmission settings, patterns of re-infection for each schistosome species were different such that generalizations across foci were difficult. For example, at the 6-month follow-up, re-infection rates were higher for S. haematobium than for S. mansoni with re-infection rates for S. haematobium varying from 9.5% to 66.7%, while for S. mansoni, lower rates were observed, ranging between nil and 24.5%. At the 12-month follow-up, re-infection rates varied from 9.1% to 66.7% for S. haematobium and from nil to 27.6% for S. mansoni. Alongside these parasitological studies, concurrent malacological surveys took place to monitor the presence of intermediate host snails of schistosomiasis. In the two northern settings, three species of Bulinus (intermediate host snail of S. haematobium) were collected; i.e. Bulinus truncatus, B. globosus and B. senegalensis, however, Biomphalaria pfeifferi (intermediate host snail of S. mansoni) was much rarer despite repeated and intensive searching and was suggestive of limited local transmission potential of S. mansoni during this time. While this study highlights that performance of PZQ was satisfactory in this region, with somewhat greater impact upon intestinal than urogenital schistosomiasis, the dynamics of local transmission are shown, however, to be complex.
机译:定期向学龄儿童(和其他高危人群)施用驱虫药吡喹酮(PZQ)是控制血吸虫病的基石。虽然PZQ对抗单一血吸虫物种感染的性能众所周知,但针对混合物种感染的性能却较差,治疗后的再感染也是如此。为了解决这个问题,在喀麦隆北部的两个肠道-泌尿生殖道血吸虫病混合灶(贝索姆和欧鲁-杜克杜杰)和一个单一的肠道中进行了一项使用PZQ双重治疗的研究,以40 mg / kg的剂量间隔3周血吸虫病感染重点(Makenene)。在治疗后的1年中,总共进行了近1000名儿童的检查,并在几次寄生虫学随访中对感染了血吸虫的儿童进行了重新检查。对血吸虫的总治愈率。在这三个设置中,Bessoum的良好率为83.3%(95%置信区间(CI)= 77.9-87.7%),Ouro Doukoudje为89.0%(95%CI = 79.1-94.6%),95.3%(95%CI = 89.5-98.0%)。有趣的是,治疗后未发现混合性血吸虫感染病例。曼氏葡萄球菌的治愈率从99.5%到100%不等,而血球链球菌的治愈率则低得多,从82.7%到88.0%不等。在不同的传播环境中,每个血吸虫物种的再感染方式都不同,因此很难在病灶之间进行概括。例如,在6个月的随访中,血吸虫的再感染率高于曼氏沙门氏菌,血吸虫的再感染率在9.5%至66.7%之间,而曼氏沙门氏菌的再感染率在9.5%至66.7%之间。观察到较低的比率,介于零至24.5%之间。在为期12个月的随访中,沙门氏菌的再感染率从9.1%到66.7%不等,曼氏沙门氏菌的再感染率从零到27.6%不等。除了这些寄生虫学研究外,还进行了并行的乳腺疾病调查,以监测血吸虫病中间宿主蜗牛的存在。在北部的两个地区,收集了3种Bulinus(S。haematobium的中间寄主蜗牛)。即t藜,球形双歧杆菌和塞内加尔双歧杆菌,尽管如此,尽管反复反复搜索,Biomphalaria pfeifferi(曼氏沙门氏菌的中间寄主蜗牛)却很少见,这表明曼氏沙门氏菌在此期间的局部传播潜力有限。尽管这项研究强调了PZQ在该区域的表现令人满意,但对肠道的影响比泌尿生殖道血吸虫病大,但局部传播的动态却很复杂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号